NCT04544748 2024-03-06A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesAO GENERIUMPhase 1 Unknown48 enrolled
NCT04697446 2021-08-10External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCBlueprint Medicines CorporationUnknown279 enrolled